发明名称 |
COMPOSITIONS AND METHODS OF USING MODIFIED RELEASE SOLABEGRON FOR LOWER URINARY TRACT SYMPTOMS |
摘要 |
This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system. |
申请公布号 |
US2016158176(A1) |
申请公布日期 |
2016.06.09 |
申请号 |
US201514958610 |
申请日期 |
2015.12.03 |
申请人 |
VELICEPT THERAPEUTICS, INC. |
发明人 |
OHLSTEIN Eliot;STEVENS, JR. Raymond E.;WILKINS H. Jeffrey |
分类号 |
A61K31/196;A61K9/00;A61K9/20;A61K9/24;A61K45/06;A61K9/16 |
主分类号 |
A61K31/196 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition comprising a therapeutically effective amount of solabegron, wherein the pharmaceutical composition achieves a first target Cmax, a second target Cmax, a first target Cmin between the first target Cmax and the second target Cmax, and a second target Cmin after the second target Cmax. |
地址 |
Malvern PA US |